---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290863097.md"
description: "Oramed shares are trading higher after the company released CEO letter to shareholders, highlighting Russell 2000/3000 index inclusion, Scilex loan repayment, and a strengthened balance sheet."
datetime: "2026-06-25T17:03:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290863097.md)
  - [en](https://longbridge.com/en/news/290863097.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290863097.md)
generator: "portal-rs"
---

# 

Oramed shares are trading higher after the company released CEO letter to shareholders, highlighting Russell 2000/3000 index inclusion, Scilex loan repayment, and a strengthened balance sheet.

### Related Stocks

- [SCLX.US](https://longbridge.com/en/quote/SCLX.US.md)
- [ORMP.US](https://longbridge.com/en/quote/ORMP.US.md)

## Related News & Research

- [Oramed Pharmaceuticals announces annual shareholder meeting](https://longbridge.com/en/news/294731948.md)
- [Scilex signs term sheet for USD 100 million private placement at USD 15 per share with iHolding Group](https://longbridge.com/en/news/291784583.md)
- [Scilex establishes uncommitted revolving credit line of up to $20 million for Vivasor](https://longbridge.com/en/news/295711735.md)
- [Oramed CFO Avraham Gabay sells 73,360 shares for $330,646.76](https://longbridge.com/en/news/291589297.md)
- [Oramed Pharmaceuticals COO & Cbo Sold Shares Worth Over $611K](https://longbridge.com/en/news/291590990.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**